AZD4831
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for AZD4831, covering 2017-01-06 to 2025-08-27. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Efficacy and Safety of AZD4831 in Participants With Heart Failure With Left Ventricular Ejection Fraction > 40% [Phase 2, Phase 3]